91 related articles for article (PubMed ID: 15021891)
1. Oncogenic aberrations of cullin-dependent ubiquitin ligases.
Guardavaccaro D; Pagano M
Oncogene; 2004 Mar; 23(11):2037-49. PubMed ID: 15021891
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin and breast cancer.
Ohta T; Fukuda M
Oncogene; 2004 Mar; 23(11):2079-88. PubMed ID: 15021895
[TBL] [Abstract][Full Text] [Related]
3. Nedd8 on cullin: building an expressway to protein destruction.
Pan ZQ; Kentsis A; Dias DC; Yamoah K; Wu K
Oncogene; 2004 Mar; 23(11):1985-97. PubMed ID: 15021886
[TBL] [Abstract][Full Text] [Related]
4. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
Motegi A; Murakawa Y; Takeda S
Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-mediated proteolysis: biological regulation via destruction.
Ciechanover A; Orian A; Schwartz AL
Bioessays; 2000 May; 22(5):442-51. PubMed ID: 10797484
[TBL] [Abstract][Full Text] [Related]
6. Cullin 3, a cellular scripter of the non-proteolytic ubiquitin code.
Jerabkova K; Sumara I
Semin Cell Dev Biol; 2019 Sep; 93():100-110. PubMed ID: 30586619
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition: mechanism of action.
DeMartino GN
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
Masucci MG
Oncogene; 2004 Mar; 23(11):2107-15. PubMed ID: 15021898
[TBL] [Abstract][Full Text] [Related]
9. The CUL4 enigma: culling DNA repair factors.
Sugasawa K
Mol Cell; 2009 May; 34(4):403-4. PubMed ID: 19481520
[TBL] [Abstract][Full Text] [Related]
10. In vitro cleavage of Nedd8 from cullin 1 by COP9 signalosome and deneddylase 1.
Yamoah K; Wu K; Pan ZQ
Methods Enzymol; 2005; 398():509-22. PubMed ID: 16275355
[TBL] [Abstract][Full Text] [Related]
11. How the ubiquitin-proteasome system controls transcription.
Muratani M; Tansey WP
Nat Rev Mol Cell Biol; 2003 Mar; 4(3):192-201. PubMed ID: 12612638
[TBL] [Abstract][Full Text] [Related]
12. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis.
Bashir T; Pagano M
Adv Cancer Res; 2003; 88():101-44. PubMed ID: 12665054
[TBL] [Abstract][Full Text] [Related]
13. Dynamic regulation of ubiquitin-dependent cell cycle control.
Craney A; Rape M
Curr Opin Cell Biol; 2013 Dec; 25(6):704-10. PubMed ID: 23890701
[TBL] [Abstract][Full Text] [Related]
14. Cullin 3 as a novel target in diverse pathologies.
Andérica-Romero AC; González-Herrera IG; Santamaría A; Pedraza-Chaverri J
Redox Biol; 2013 Jul; 1(1):366-72. PubMed ID: 24024173
[TBL] [Abstract][Full Text] [Related]
15. Plant CULLIN-based E3s: phytohormones come first.
Thomann A; Dieterle M; Genschik P
FEBS Lett; 2005 Jun; 579(15):3239-45. PubMed ID: 15943967
[TBL] [Abstract][Full Text] [Related]
16. BTB proteins as henchmen of Cul3-based ubiquitin ligases.
Krek W
Nat Cell Biol; 2003 Nov; 5(11):950-1. PubMed ID: 14593416
[No Abstract] [Full Text] [Related]
17. Control of the centriole and centrosome cycles by ubiquitination enzymes.
Hansen DV; Hsu JY; Kaiser BK; Jackson PK; Eldridge AG
Oncogene; 2002 Sep; 21(40):6209-21. PubMed ID: 12214251
[No Abstract] [Full Text] [Related]
18. Systematic and quantitative assessment of the ubiquitin-modified proteome.
Kim W; Bennett EJ; Huttlin EL; Guo A; Li J; Possemato A; Sowa ME; Rad R; Rush J; Comb MJ; Harper JW; Gygi SP
Mol Cell; 2011 Oct; 44(2):325-40. PubMed ID: 21906983
[TBL] [Abstract][Full Text] [Related]
19. Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis.
Zhou Y; Li M; Shen T; Yang T; Shi G; Wei Y; Chen C; Wang D; Wang Y; Zhang T
ACS Chem Biol; 2022 Oct; 17(10):2734-2743. PubMed ID: 36076154
[TBL] [Abstract][Full Text] [Related]
20. On the eve of protein destruction: ubiquitin research begins to pay off.
Garber K
J Natl Cancer Inst; 2002 Apr; 94(8):550-2. PubMed ID: 11959885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
